The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Coverage in the US: a map of the usual obstacles

This is a generated summary. It shows the 7 most-liked posts from a topic of 51, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
KH
ka.haddadTL2 Moderator24 Oct 2025#4

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

28 likes 9mo
FK
f.kimaniTL2 Moderator6 Dec 2025#19
j.iyer, post #11: This follows post #8 rather than contradicting it. Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream healthcare. Go to post

Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.

20 likes in reply to #11 8mo
TI
trough_indexTL3Regular16 Dec 2025#23

Compounding pharmacies: pharmaceutical compounding of a drug not on the FDA shortage list is substantially constrained. The landscape changed when supply normalised. Current compounding availability is limited.

30 likes 7mo
L
LJankowiakTL3Regular25 Dec 2025#27

Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream healthcare.

22 likes 7mo
N
NicolaidesTL3Regular12 Jan 2026#35

Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.

26 likes 6mo
CL
customs_ledgerTL3Regular25 Jan 2026#41

On post #37 — agreed on the reasoning, with one qualification.

Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.

27 likes 6mo
JF
j.falkTL2 Moderator12 Feb 2026#50

Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.

26 likes 5mo

Read the full topic (51 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
POCLNNTPFV+74 80 7.7k 18mo
Revisiting: US compounding rules and how they changed
On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
LECKDHKI+5 9 26k 23mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
SAEDERSGAK 4 62k 9mo
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
LCNBHFTIEM+26 30 17k 17h
Canadian access and provincial variation — one year on
Canadian access and provincial variation — one year on Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
EOHFCRJSRM+43 47 964 12mo

Related topics — sharing the tags FDA, insurance, telehealth

TopicParticipantsRepliesViewsActivity
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
KTVEKCNB+3 7 43k 9mo
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
SCHBFPNVHS+20 25 50k 1d
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
SPVBAKTWFA+85 92 5.5k 11mo
Coverage for the indication versus for the drug — a second dataset
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is…
TSEFKJHV+46 50 41k 16mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
SAEDERSGAK 4 62k 9mo